Insider at Treace Medical Concepts (TMCI) reports 4,544-share move

Rhea-AI Filing Summary

Treace Medical Concepts, Inc. officer Elder Scot Michael, Chief Legal & Compliance Officer and Corporate Secretary, reported a transaction in company common stock dated 01/10/2026. A transaction coded "F" involved 4,544 shares at a reported price of $0 per share, after which he beneficially owned 543,737 common shares. This beneficial ownership figure includes 410,845 restricted stock units.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Elder Scot Michael

Role Chief Legl & Comp Off, CorpSec

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	4,544	$0.00	--

Holdings After Transaction: Common Stock — 543,737 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Elder Scot Michael

(Last) (First) (Middle)

C/O TREACE MEDICAL CONCEPTS, INC.

100 PALMETTO PARK PLACE

(Street)

PONTE VEDRA FL 32081

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TREACE MEDICAL CONCEPTS, INC. [ TMCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legl & Comp Off, CorpSec

3. Date of Earliest Transaction (Month/Day/Year)
01/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/10/2026		F		4,544	D	$0	543,737(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 410,845 restricted stock units.

	/s/ Lisa Taylor as Attorney-in-fact for Scot Elder	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did TMCI report for Elder Scot Michael?

Elder Scot Michael reported a transaction in 4,544 shares of Treace Medical Concepts, Inc. common stock on 01/10/2026, coded as transaction type F.

How many TMCI shares does Elder Scot Michael beneficially own after this transaction?

Following the reported transaction, Elder Scot Michael beneficially owns 543,737 shares of Treace Medical Concepts, Inc. common stock.

What portion of Elder Scot Michaels TMCI holdings are restricted stock units?

His reported beneficial ownership includes 410,845 restricted stock units of Treace Medical Concepts, Inc.

Was the TMCI insider transaction reported as direct or indirect ownership?

The filing shows the transaction and resulting holdings as direct (D) ownership by Elder Scot Michael.

What price per share was recorded for the 4,544 TMCI shares in this insider transaction?

The 4,544-share transaction was reported at a price of $0 per share.

What role does Elder Scot Michael hold at Treace Medical Concepts, Inc. (TMCI)?

Elder Scot Michael is reported as an officer of Treace Medical Concepts, Inc., serving as Chief Legal & Compliance Officer and Corporate Secretary.